State Street
VIVO

State Street’s Meridian Bioscience Inc VIVO Stock Holding History

State Street’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,578,349
Closed -$52.4M – 4904
2022
Q4 		$52.4M Sell
1,578,349
-47,756
-3% -$1.54M ﹤0.01% 1612
2022
Q3 		$51.3M Buy
1,626,105
+108
+0% +$3.5K ﹤0.01% 1581
2022
Q2 		$49.5M Sell
1,625,997
-30,736
-2% -$831K ﹤0.01% 1641
2022
Q1 		$43M Sell
1,656,733
-79,565
-5% -$1.89M ﹤0.01% 1869
2021
Q4 		$35.4M Sell
1,736,298
-97,312
-5% -$1.87M ﹤0.01% 2065
2021
Q3 		$35.3M Buy
1,833,610
+37,659
+2% +$751K ﹤0.01% 2063
2021
Q2 		$39.8M Buy
1,795,951
+117,576
+7% +$2.49M ﹤0.01% 2018
2021
Q1 		$44.1M Sell
1,678,375
-283,030
-14% -$6.73M ﹤0.01% 1826
2020
Q4 		$36.7M Sell
1,961,405
-143,854
-7% -$2.69M ﹤0.01% 1848
2020
Q3 		$35.7M Buy
2,105,259
+44,356
+2% +$862K ﹤0.01% 1684
2020
Q2 		$48M Buy
2,060,903
+225,168
+12% +$3.26M ﹤0.01% 1487
2020
Q1 		$15.4M Buy
1,835,735
+237,787
+15% +$2M ﹤0.01% 2013
2019
Q4 		$15.6M Buy
1,597,948
+38,847
+2% +$365K ﹤0.01% 2302
2019
Q3 		$14.8M Sell
1,559,101
-98,631
-6% -$1.04M ﹤0.01% 2257
2019
Q2 		$19.7M Buy
1,657,732
+97,933
+6% +$1.18M ﹤0.01% 2118
2019
Q1 		$27.5M Buy
1,559,799
+182,132
+13% +$3.03M ﹤0.01% 1839
2018
Q4 		$23.9M Sell
1,377,667
-21,636
-2% -$369K ﹤0.01% 1860
2018
Q3 		$20.9M Buy
1,399,303
+150,149
+12% +$2.33M ﹤0.01% 2153
2018
Q2 		$19.9M Buy
1,249,154
+82,698
+7% +$1.23M ﹤0.01% 2135
2018
Q1 		$16.6M Sell
1,166,456
-87,693
-7% -$1.3M ﹤0.01% 2180
2017
Q4 		$17.6M Buy
1,254,149
+49,825
+4% +$729K ﹤0.01% 2134
2017
Q3 		$17.2M Sell
1,204,324
-26,768
-2% -$382K ﹤0.01% 2128
2017
Q2 		$19.4M Sell
1,231,092
-12,755
-1% -$184K ﹤0.01% 2014
2017
Q1 		$17.2M Buy
1,243,847
+163,770
+15% +$2.29M ﹤0.01% 2055
2016
Q4 		$19.1M Buy
1,080,077
+142,431
+15% +$2.5M ﹤0.01% 1931
2016
Q3 		$18.1M Buy
937,646
+45,186
+5% +$884K ﹤0.01% 1839
2016
Q2 		$17.4M Sell
892,460
-14,918
-2% -$293K ﹤0.01% 1852
2016
Q1 		$18.7M Sell
907,378
-43,132
-5% -$850K ﹤0.01% 1766
2015
Q4 		$19.5M Buy
950,510
+19,019
+2% +$365K ﹤0.01% 1733
2015
Q3 		$15.9M Buy
931,491
+1,877
+0.2% +$34.3K ﹤0.01% 1903
2015
Q2 		$17.3M Sell
929,614
-23,703
-2% -$440K ﹤0.01% 1950
2015
Q1 		$18.2M Buy
953,317
+92,968
+11% +$1.72M ﹤0.01% 1906
2014
Q4 		$14.2M Buy
860,349
+17,719
+2% +$304K ﹤0.01% 2007
2014
Q3 		$14.9M Sell
842,630
-2,597
-0.3% -$51K ﹤0.01% 1939
2014
Q2 		$17.4M Sell
845,227
-7,850
-0.9% -$161K ﹤0.01% 1898
2014
Q1 		$18.6M Buy
853,077
+17,321
+2% +$397K ﹤0.01% 1843
2013
Q4 		$22.2M Sell
835,756
-228
-0% -$5.6K ﹤0.01% 1681
2013
Q3 		$19.8M Buy
835,984
+12,286
+1% +$287K ﹤0.01% 1712
2013
Q2 		$17.7M Buy
+823,698
New +$17.8M ﹤0.01% 1710

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

State Street's VIVO Position: Q1 2023 in Review

State Street sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 1,578,349 shares — an estimated $52.4M sold.

State Street first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $52.4M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • State Street reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • State Street sold 1,578,349 Meridian Bioscience Inc shares in Q1 2023, an estimated $52.4M.
  • State Street first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • State Street's Meridian Bioscience Inc position peaked at $52.4M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.